Cargando…

A competing risk analysis of colorectal cancer recurrence after curative surgery

BACKGROUND: This study examines the effect of prognostic patient and disease characteristics on colorectal cancer (CRC) recurrence after curative resection. We used competing risk analysis with death as a competing risk. This method provides the clinician a perspective into a patient’s actual risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Schellenberg, Angela E., Moravan, Veronika, Christian, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896382/
https://www.ncbi.nlm.nih.gov/pubmed/35241002
http://dx.doi.org/10.1186/s12876-022-02161-9
_version_ 1784663151055208448
author Schellenberg, Angela E.
Moravan, Veronika
Christian, Francis
author_facet Schellenberg, Angela E.
Moravan, Veronika
Christian, Francis
author_sort Schellenberg, Angela E.
collection PubMed
description BACKGROUND: This study examines the effect of prognostic patient and disease characteristics on colorectal cancer (CRC) recurrence after curative resection. We used competing risk analysis with death as a competing risk. This method provides the clinician a perspective into a patient’s actual risk of experiencing a recurrence. METHODS: A retrospective cohort study of patients diagnosed with CRC who underwent curative resection for CRC from 2003–2007 at the Royal University Hospital in Saskatoon was completed. The outcome of interest was the first CRC recurrence, either local or distant metastasis. Demographic data, tumor characteristics, adjuvant treatment and follow-up data, date of local recurrence or metastasis were recorded from the medical record. Univariate analysis was completed to look at the relationship between each of the prognostic indicators and recurrence. Multivariable modelling (subdistribution regression modelling) was done to identify the main risk factors in determining recurrence. RESULTS: Of 148 patients, 38 (25.7%) experienced a recurrence, 16 (10.8%) died without evidence of recurrence, and 94 (63.5%) experienced neither outcome. The median follow-up was 30.5 months (interquartile range 10.6–50). In univariable subdistribution regression, T-stage, N-stage, vascular invasion and positive margins were all predictive of cancer recurrence, with p ≤ 0.001, with subdistribution hazard ratios for T4 stage at 11.93, T3 stage at 2.46, N2 stage at 10.58, and presence of vascular invasion at 4.27. N-stage remained as the sole predictor in multivariable regression. Cumulative incidence function (CIF) of recurrence at 48 months after surgery was 15%, 27% and 90% for N1/2, N3 and N4 respectively. CONCLUSION: The highest CIF of recurrence was associated with T4 stage, N2 stage, and vascular invasion. Patient’s age, tumour location, type, or histological grade were not found to have a significant effect on the success of CRC surgery in precluding a recurrence.
format Online
Article
Text
id pubmed-8896382
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88963822022-03-14 A competing risk analysis of colorectal cancer recurrence after curative surgery Schellenberg, Angela E. Moravan, Veronika Christian, Francis BMC Gastroenterol Research Article BACKGROUND: This study examines the effect of prognostic patient and disease characteristics on colorectal cancer (CRC) recurrence after curative resection. We used competing risk analysis with death as a competing risk. This method provides the clinician a perspective into a patient’s actual risk of experiencing a recurrence. METHODS: A retrospective cohort study of patients diagnosed with CRC who underwent curative resection for CRC from 2003–2007 at the Royal University Hospital in Saskatoon was completed. The outcome of interest was the first CRC recurrence, either local or distant metastasis. Demographic data, tumor characteristics, adjuvant treatment and follow-up data, date of local recurrence or metastasis were recorded from the medical record. Univariate analysis was completed to look at the relationship between each of the prognostic indicators and recurrence. Multivariable modelling (subdistribution regression modelling) was done to identify the main risk factors in determining recurrence. RESULTS: Of 148 patients, 38 (25.7%) experienced a recurrence, 16 (10.8%) died without evidence of recurrence, and 94 (63.5%) experienced neither outcome. The median follow-up was 30.5 months (interquartile range 10.6–50). In univariable subdistribution regression, T-stage, N-stage, vascular invasion and positive margins were all predictive of cancer recurrence, with p ≤ 0.001, with subdistribution hazard ratios for T4 stage at 11.93, T3 stage at 2.46, N2 stage at 10.58, and presence of vascular invasion at 4.27. N-stage remained as the sole predictor in multivariable regression. Cumulative incidence function (CIF) of recurrence at 48 months after surgery was 15%, 27% and 90% for N1/2, N3 and N4 respectively. CONCLUSION: The highest CIF of recurrence was associated with T4 stage, N2 stage, and vascular invasion. Patient’s age, tumour location, type, or histological grade were not found to have a significant effect on the success of CRC surgery in precluding a recurrence. BioMed Central 2022-03-03 /pmc/articles/PMC8896382/ /pubmed/35241002 http://dx.doi.org/10.1186/s12876-022-02161-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Schellenberg, Angela E.
Moravan, Veronika
Christian, Francis
A competing risk analysis of colorectal cancer recurrence after curative surgery
title A competing risk analysis of colorectal cancer recurrence after curative surgery
title_full A competing risk analysis of colorectal cancer recurrence after curative surgery
title_fullStr A competing risk analysis of colorectal cancer recurrence after curative surgery
title_full_unstemmed A competing risk analysis of colorectal cancer recurrence after curative surgery
title_short A competing risk analysis of colorectal cancer recurrence after curative surgery
title_sort competing risk analysis of colorectal cancer recurrence after curative surgery
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896382/
https://www.ncbi.nlm.nih.gov/pubmed/35241002
http://dx.doi.org/10.1186/s12876-022-02161-9
work_keys_str_mv AT schellenbergangelae acompetingriskanalysisofcolorectalcancerrecurrenceaftercurativesurgery
AT moravanveronika acompetingriskanalysisofcolorectalcancerrecurrenceaftercurativesurgery
AT christianfrancis acompetingriskanalysisofcolorectalcancerrecurrenceaftercurativesurgery
AT schellenbergangelae competingriskanalysisofcolorectalcancerrecurrenceaftercurativesurgery
AT moravanveronika competingriskanalysisofcolorectalcancerrecurrenceaftercurativesurgery
AT christianfrancis competingriskanalysisofcolorectalcancerrecurrenceaftercurativesurgery